Thermo Fisher Scientific Other Current Assets 2010-2024 | TMO
Thermo Fisher Scientific other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Thermo Fisher Scientific other current assets for the quarter ending September 30, 2024 were $3.452B, a 9% increase year-over-year.
- Thermo Fisher Scientific other current assets for 2023 were $3.203B, a 8.36% increase from 2022.
- Thermo Fisher Scientific other current assets for 2022 were $2.956B, a 13.34% increase from 2021.
- Thermo Fisher Scientific other current assets for 2021 were $2.608B, a 40.06% increase from 2020.
| Thermo Fisher Scientific Annual Other Current Assets (Millions of US $) |
|
|---|---|
| 2023 | $3,203 |
| 2022 | $2,956 |
| 2021 | $2,608 |
| 2020 | $1,862 |
| 2019 | $1,775 |
| 2018 | $1,381 |
| 2017 | $1,236 |
| 2016 | $595 |
| 2015 | $534 |
| 2014 | $560 |
| 2013 | $421 |
| 2012 | $595 |
| 2011 | $550 |
| 2010 | $381 |
| 2009 | $259 |
| Thermo Fisher Scientific Quarterly Other Current Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $3,452 |
| 2024-06-30 | $3,512 |
| 2024-03-31 | $3,326 |
| 2023-12-31 | $3,200 |
| 2023-09-30 | $3,167 |
| 2023-06-30 | $3,188 |
| 2023-03-31 | $3,141 |
| 2022-12-31 | $2,956 |
| 2022-09-30 | $2,987 |
| 2022-06-30 | $2,799 |
| 2022-03-31 | $2,652 |
| 2021-12-31 | $2,608 |
| 2021-09-30 | $2,234 |
| 2021-06-30 | $2,136 |
| 2021-03-31 | $2,206 |
| 2020-12-31 | $1,862 |
| 2020-09-30 | $1,679 |
| 2020-06-30 | $1,831 |
| 2020-03-31 | $1,795 |
| 2019-12-31 | $1,775 |
| 2019-09-30 | $1,549 |
| 2019-06-30 | $1,597 |
| 2019-03-31 | $1,554 |
| 2018-12-31 | $1,381 |
| 2018-09-30 | $1,229 |
| 2018-06-30 | $1,230 |
| 2018-03-31 | $1,217 |
| 2017-12-31 | $1,236 |
| 2017-09-30 | $768 |
| 2017-06-30 | $746 |
| 2017-03-31 | $684 |
| 2016-12-31 | $595 |
| 2016-09-30 | $948 |
| 2016-06-30 | $873 |
| 2016-03-31 | $889 |
| 2015-12-31 | $534 |
| 2015-09-30 | $728 |
| 2015-06-30 | $589 |
| 2015-03-31 | $571 |
| 2014-12-31 | $560 |
| 2014-09-30 | $525 |
| 2014-06-30 | $507 |
| 2014-03-31 | $797 |
| 2013-12-31 | $421 |
| 2013-09-30 | $687 |
| 2013-06-30 | $660 |
| 2013-03-31 | $567 |
| 2012-12-31 | $595 |
| 2012-09-30 | $567 |
| 2012-06-30 | $558 |
| 2012-03-31 | $500 |
| 2011-12-31 | $550 |
| 2011-09-30 | $415 |
| 2011-06-30 | $412 |
| 2011-03-31 | $382 |
| 2010-12-31 | $381 |
| 2010-09-30 | $293 |
| 2010-06-30 | $248 |
| 2010-03-31 | $279 |
| 2009-12-31 | $259 |
| 2009-09-30 | $227 |
| 2009-06-30 | $224 |
| 2009-03-31 | $212 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $214.066B | $42.857B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $211.086B | 110.36 |
| Alcon (ALC) | Switzerland | $41.615B | 27.84 |
| Edwards Lifesciences (EW) | United States | $41.156B | 26.14 |
| IQVIA Holdings (IQV) | United States | $35.821B | 19.74 |
| IDEXX Laboratories (IDXX) | United States | $34.331B | 40.43 |
| DexCom (DXCM) | United States | $32.958B | 49.63 |
| Waters (WAT) | United States | $23.988B | 35.47 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.710B | 0.00 |
| Hologic (HOLX) | United States | $15.740B | 17.09 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.538B | 13.90 |
| Globus Medical (GMED) | United States | $12.364B | 31.31 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 36.77 |
| Penumbra (PEN) | United States | $10.120B | 99.13 |
| Masimo (MASI) | United States | $9.225B | 44.63 |
| Glaukos (GKOS) | United States | $8.623B | 0.00 |
| Teleflex (TFX) | United States | $8.419B | 13.43 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.657B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.967B | 0.00 |
| Veracyte (VCYT) | United States | $3.145B | 94.37 |
| Nihon Kohden (NHNKY) | Japan | $2.658B | 20.19 |
| LivaNova (LIVN) | United Kingdom | $2.623B | 15.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.309B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 19.48 |
| TransMedics (TMDX) | United States | $1.920B | 60.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| Alphatec Holdings (ATEC) | United States | $1.641B | 0.00 |
| Artivion (AORT) | United States | $1.288B | 85.33 |
| RxSight (RXST) | United States | $1.225B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.083B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.911B | 0.00 |
| AxoGen (AXGN) | United States | $0.796B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.758B | 17.88 |
| IRadimed (IRMD) | United States | $0.750B | 40.53 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.732B | 12.44 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.693B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.658B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.599B | 31.55 |
| Treace Medical Concepts (TMCI) | United States | $0.543B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.503B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.458B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| CVRx (CVRX) | United States | $0.428B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.418B | 22.60 |
| ClearPoint Neuro (CLPT) | United States | $0.415B | 0.00 |
| NeuroPace (NPCE) | United States | $0.357B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Accuray (ARAY) | United States | $0.225B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 11.51 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.071B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.93 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.008B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |